Lista de obras -

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

artículo científico publicado en 2018

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

artículo científico publicado en 2014

Association of the metabolic syndrome with pulmonary venous hypertension

artículo científico publicado en 2009

BMPR2 dysfunction impairs insulin signaling and glucose homeostasis in cardiomyocytes

artículo científico publicado en 2019

Causes of pulmonary hypertension in the elderly

artículo científico publicado en 2014

Clinical Trials in Pulmonary Hypertension: Time for a Consortium ⬇️

artículo científico publicado el 1 de enero de 2013

Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.

artículo científico publicado en 2016

Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan

artículo científico publicado en 2011

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension

artículo científico

Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge

artículo científico publicado en 2019

Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension

artículo científico publicado en 2015

End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment

artículo científico publicado en 2011

End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension.

artículo científico publicado en 2017

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

artículo científico publicado en 2017

Evidence for inflammatory signaling in idiopathic pulmonary artery hypertension: TRPC6 and nuclear factor-kappaB.

artículo científico publicado en 2009

Exercise training in pulmonary hypertension: implications for the evaluation of drug trials

artículo científico publicado en 2006

Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

artículo científico publicado en 2016

Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance

artículo científico publicado en 2008

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

artículo científico publicado en 2004

Genetics and genomics of pulmonary arterial hypertension

artículo científico publicado en 2013

Genetics and genomics of pulmonary arterial hypertension

artículo científico publicado en 2009

Giants in chest medicine: Richard W. Light, MD.

artículo científico publicado en 2014

Hemodynamic Improvement of Pulmonary Arterial Hypertension After Bariatric Surgery: Potential Role for Metabolic Regulation ⬇️

artículo científico publicado el 1 de marzo de 2013

Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension

artículo científico publicado en 2016

High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension

artículo científico publicado en 2013

High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective

artículo científico publicado en 2010

High‐Altitude Pulmonary Hypertension in Cattle (Brisket Disease): Candidate Genes and Gene Expression Profiling of Peripheral Blood Mononuclear Cells ⬇️

artículo científico publicado el 1 de octubre de 2011

Human PAH is characterized by a pattern of lipid-related insulin resistance

scholarly article by Anna R Hemnes et al published 10 January 2019 in JCI insight

IRF2BPL Is Associated with Neurological Phenotypes

Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.

artículo científico publicado en 2011

IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells.

artículo científico publicado en 2019

Increased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension

artículo científico publicado en 2015

Inflammation, growth factors, and pulmonary vascular remodeling

artículo científico publicado en 2009

Inhibition of endogenous nitric oxide during endotoxemia in awake sheep - effects of Nomega-nitro-l-arginine on the distribution of pulmonary vascular resistance and prostanoid products

artículo científico publicado en 2002

Limitations of exome sequencing in detecting rare and undiagnosed diseases

scientific article published on 19 March 2020

Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.

artículo científico publicado en 2012

Lungs at high-altitude: genomic insights into hypoxic responses

artículo científico

Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

scientific article published on 21 June 2019

Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle

artículo científico publicado en 2016

Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies

artículo científico publicado en 2008

New risks for pulmonary hypertension: need for a large epidemiologic study

artículo científico publicado en 2006

PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics

artículo científico publicado en 2017

Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele

artículo científico publicado en 2009

Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.

artículo científico publicado en 2014

Phenotypic heterogeneity of ZMPSTE24 deficiency

artículo científico publicado en 2018

Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.

artículo científico publicado en 2012

Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension

artículo científico publicado en 2013

Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension

artículo científico publicado en 2013

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects

artículo científico publicado en 2015

Pulmonary Hypertension by the Method of Paul Wood

artículo científico publicado en 2020

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop

artículo científico publicado en 2004

Pulmonary hypertension

artículo científico publicado en 2005

Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension

artículo científico publicado en 2017

Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

artículo científico publicado en 2002

Rare variants in the gene ALPL that cause hypophosphatasia are strongly associated with ovarian and uterine disorders.

artículo científico publicado en 2018

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

artículo científico

Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension

artículo científico publicado en 2005

Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function

artículo científico publicado en 2013

Six-minute walk distance in healthy young adults

artículo científico publicado en 2020

Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report

artículo científico publicado en 2010

Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension

artículo científico publicado en 2008

Testosterone Negatively Regulates Right Ventricular Load Stress Responses in Mice ⬇️

artículo científico publicado el 1 de julio de 2012

The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes

artículo científico publicado en 2015

The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens

artículo científico publicado en 2018

The first annual Drug Discovery and Development Symposium for Pulmonary Hypertension

artículo científico publicado en 2014

Treatment of primary pulmonary hypertension -- the next generation

artículo científico publicado en 2002

Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

artículo científico publicado en 2009

Unrecognized glucose intolerance is common in pulmonary arterial hypertension

artículo científico publicado en 2011

Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers

artículo científico publicado en 2015

Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers.

artículo científico publicado en 2014

Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice-site and Charcot-Marie-Tooth phenotype with early onset symptoms

scientific article published on 25 April 2019

[Genetics and genomics of pulmonary arterial hypertension].

artículo científico publicado en 2014

[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]

artículo científico publicado en 2014

Lista de obras de

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

An official American Thoracic Society Statement: pulmonary hypertension phenotypes

Association of the metabolic syndrome with pulmonary venous hypertension

BMPR2 dysfunction impairs insulin signaling and glucose homeostasis in cardiomyocytes

Causes of pulmonary hypertension in the elderly

Clinical Trials in Pulmonary Hypertension: Time for a Consortium ⬇️

Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.

Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension

Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge

Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension

End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment

End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension.

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Evidence for inflammatory signaling in idiopathic pulmonary artery hypertension: TRPC6 and nuclear factor-kappaB.

Exercise training in pulmonary hypertension: implications for the evaluation of drug trials

Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

Genetics and genomics of pulmonary arterial hypertension

Genetics and genomics of pulmonary arterial hypertension

Giants in chest medicine: Richard W. Light, MD.

Hemodynamic Improvement of Pulmonary Arterial Hypertension After Bariatric Surgery: Potential Role for Metabolic Regulation ⬇️

Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension

High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension

High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective

High‐Altitude Pulmonary Hypertension in Cattle (Brisket Disease): Candidate Genes and Gene Expression Profiling of Peripheral Blood Mononuclear Cells ⬇️

Human PAH is characterized by a pattern of lipid-related insulin resistance

IRF2BPL Is Associated with Neurological Phenotypes

Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.

IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells.

Increased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension

Inflammation, growth factors, and pulmonary vascular remodeling

Inhibition of endogenous nitric oxide during endotoxemia in awake sheep - effects of Nomega-nitro-l-arginine on the distribution of pulmonary vascular resistance and prostanoid products

Limitations of exome sequencing in detecting rare and undiagnosed diseases

Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.

Lungs at high-altitude: genomic insights into hypoxic responses

Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle

Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies

New risks for pulmonary hypertension: need for a large epidemiologic study

PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics

Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele

Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.

Phenotypic heterogeneity of ZMPSTE24 deficiency

Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.

Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension

Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects

Pulmonary Hypertension by the Method of Paul Wood

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop

Pulmonary hypertension

Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension

Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

Rare variants in the gene ALPL that cause hypophosphatasia are strongly associated with ovarian and uterine disorders.

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension

Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function

Six-minute walk distance in healthy young adults

Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report

Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension

Testosterone Negatively Regulates Right Ventricular Load Stress Responses in Mice ⬇️

The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes

The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens

The first annual Drug Discovery and Development Symposium for Pulmonary Hypertension

Treatment of primary pulmonary hypertension -- the next generation

Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

Unrecognized glucose intolerance is common in pulmonary arterial hypertension

Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers

Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers.

Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice-site and Charcot-Marie-Tooth phenotype with early onset symptoms

[Genetics and genomics of pulmonary arterial hypertension].

[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]